305 related articles for article (PubMed ID: 4007926)
1. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.
Thomsen AR; Volkert M; Marker O
Immunology; 1985 Jun; 55(2):213-23. PubMed ID: 4007926
[TBL] [Abstract][Full Text] [Related]
2. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
Byrne JA; Oldstone MB
J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
[TBL] [Abstract][Full Text] [Related]
3. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
[TBL] [Abstract][Full Text] [Related]
4. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
[TBL] [Abstract][Full Text] [Related]
5. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection.
Moskophidis D; Lehmann-Grube F
J Immunol; 1984 Dec; 133(6):3366-70. PubMed ID: 6092472
[TBL] [Abstract][Full Text] [Related]
6. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
[TBL] [Abstract][Full Text] [Related]
8. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection.
Buchmeier MJ; Oldstone MB
J Immunol; 1978 Apr; 120(4):1297-304. PubMed ID: 76662
[TBL] [Abstract][Full Text] [Related]
9. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
[TBL] [Abstract][Full Text] [Related]
10. The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus.
Thomsen AR; Marker O
Immunology; 1988 Sep; 65(1):9-15. PubMed ID: 3263315
[TBL] [Abstract][Full Text] [Related]
11. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
Battegay M; Moskophidis D; Waldner H; Bründler MA; Fung-Leung WP; Mak TW; Hengartner H; Zinkernagel RM
J Immunol; 1993 Nov; 151(10):5408-15. PubMed ID: 7693811
[TBL] [Abstract][Full Text] [Related]
12. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
13. Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions.
Molina TJ; Bachmann MF; Kündig TM; Zinkernagel RM; Mak TW
J Immunol; 1993 Jul; 151(2):699-706. PubMed ID: 8393038
[TBL] [Abstract][Full Text] [Related]
14. Public, private and non-specific antibodies induced by non-cytopathic viral infections.
Recher M; Hunziker L; Ciurea A; Harris N; Lang KS
Curr Opin Microbiol; 2004 Aug; 7(4):426-33. PubMed ID: 15358263
[TBL] [Abstract][Full Text] [Related]
15. Immunity to lymphocytic choriomeningitis virus in B cell-depleted mice: evidence for B cell and antibody-independent protection by memory T cells.
Cerny A; Huegin AW; Sutter S; Bazin H; Hengartner HH; Zinkernagel RM
Eur J Immunol; 1986 Aug; 16(8):913-7. PubMed ID: 3488911
[TBL] [Abstract][Full Text] [Related]
16. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice.
Razvi ES; Welsh RM; McFarland HI
J Immunol; 1995 Jan; 154(2):620-32. PubMed ID: 7529281
[TBL] [Abstract][Full Text] [Related]
17. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].
Planz O; Seiler P; Hengartner H; Zinkernagel RM
Nature; 1996 Aug; 382(6593):726-9. PubMed ID: 8751445
[TBL] [Abstract][Full Text] [Related]
18. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.
Von Herrath MG; Coon B; Oldstone MB
Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248
[TBL] [Abstract][Full Text] [Related]
19. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
[TBL] [Abstract][Full Text] [Related]
20. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
Evans CF; Rall GF; Killeen N; Littman D; Oldstone MB
J Immunol; 1993 Dec; 151(11):6259-64. PubMed ID: 7902375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
